Hotline: 1800 102 2007
X
Search Business Opportunities
Jan, 10 2018

Hilleman Labs Partners With Future Vaccine Manufacturing Hub

The hub will collaborate with the Developing Countries Vaccine Manufacturing Network on manufacturing projects in India Vietnam Bangladesh Uganda and China

Hilleman Laboratories to collaborate with Imperial College London, Engineering and Physical Sciences Research Council (UK) and other premier international bodies towards low-cost vaccine manufacturing.

Hilleman Laboratories, an equal joint-venture partnership between MSD and Welcome Trust, is one of the key partners of the new Future Vaccine Manufacturing Hub led by Imperial College London. The hub has been established to increase immunisation coverage across the globe and improve the response to disease outbreaks through the rapid and cost-effective deployment of vaccines. £10 million of funding has been granted by the UK Department for Health, and will be managed by the Engineering and Physical Sciences Research Council (EPSRC).

Speaking on the occasion, Dr Davinder Gill, CEO Hilleman Laboratories said, “We are honoured to collaborate with Imperial College London and EPSRC in the United Kingdom. We are gratified with this collaboration, which will help us develop our competences through international partnerships. As a partner in manufacturing research projects, we are truly hoping that the new Vaccine Manufacturing Hub will increase immunisation coverage around the globe and respond to disease outbreaks with safe and cost-effective vaccines. It will allow us to invest in innovation more effectively to explore high-quality vaccines & technologies.”

The hub will collaborate with the Developing Countries Vaccine Manufacturing Network on manufacturing projects in India, Vietnam, Bangladesh, Uganda and China. Integrated approaches that will be explored by researchers at the Hub include the development of synthetic RNA vaccines which can be rapidly manufactured; the rapid production of yeast and bacterially-expressed particles that mimic components of pathogenic viruses and bacteria; and protein stabilisation to preserve vaccines at high temperatures, avoiding the need for refrigerated distribution and storage.

Comment
image
Related opportunities
  • Others Food Service
    About Us: Kake Di Hatti, an iconic eatery located in the..
    Locations looking for expansion Delhi
    Establishment year 1950
    Franchising Launch Date 1989
    Investment size Rs. 20lac - 30lac
    Space required 900
    Franchise Outlets -NA-
    Franchise Type Unit
    Headquater Delhi Delhi
  • Fine Dine Restaurants
    About Us: MOTI MAHAL DELUXE commenced its operations in 1978 and since..
    Locations looking for expansion Delhi
    Establishment year 1978
    Franchising Launch Date 1990
    Investment size Rs. 50lac - 1 Cr.
    Space required 300
    Franchise Outlets -NA-
    Franchise Type Unit
    Headquater New delhi Delhi
  • About Us: Attitude is a distinguished brand name that has carved..
    Locations looking for expansion Maharashtra
    Establishment year 1986
    Franchising Launch Date 2017
    Investment size Rs. 5lac - 10lac
    Space required 450
    Franchise Outlets -NA-
    Franchise Type Unit, Multiunit
    Headquater Malad west Maharashtra
  • Car Maintanance & Repair Services
    About Us: Mahindra First Choice Services (MFCS) is a..
    Locations looking for expansion Maharashtra
    Establishment year 2007
    Franchising Launch Date 2014
    Investment size Rs. 50lac - 1 Cr.
    Space required 5000
    Franchise Outlets -NA-
    Franchise Type Unit
    Headquater Mumbai Maharashtra
Insta-Subscribe to
Entrepreneur
Magazine
For hassle free instant subscription, just give your number and email id and our customer care agent will get in touch with you
OR Click here to Subscribe Online
Daily Updates
Submit your email address to receive the latest updates on news & host of opportunities